MedTrace Logo

Functional Implication of Corpus Callosum in Voluntary Strength in COPD Patients

NCT03807258 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2020-01-13

No results posted yet for this study

Summary

Patients with COPD have lower capability of activating their muscles. At the cortical level, force production is not only controlled by contralateral primary motor cortex but also by ipsilateral motor cortex. The aim of this study is to determine whether ipsilateral areas are functionally impaired in COPD.

Conditions

  • Neurophysiology
  • Physiology

Interventions

OTHER

Transcranial magnetic stimulation (TMS)

Evaluations by TMS

Sponsors & Collaborators

  • 5 Santé

    lead OTHER

Principal Investigators

  • Nicolas Oliver, MD · 5 Santé

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-20
Primary Completion
2019-03-30
Completion
2019-03-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03807258 on ClinicalTrials.gov